In this study composite coatings of polycaprolactone (PCL) and nanosized bioactive glass were produced on stainless steel by electrophoretic deposition (EPD) for biomedical applications. PCL was dissolved in dimethylcarbonate and bioactive glass nanoparticles were dispersed in ethanol for the deposition. The EPD parameters were varied in terms of voltage, deposition time, concentration of PCL and bioactive glass (BG) and pH. SEM showed that homogeneous composite coatings of about 5µm thickness were produced. Contact angle measurements indicated that the contact angle and hence the hydrophobicity of the coatings decreases with increasing BG content. The bioactivity of the coatings was investigated by assessing the formation of hydroxyapatite on coating surfaces in simulated body fluid for up to 15 days and investigating the samples by Raman spectroscopy and SEM. EPD was confirmed to be a suitable technique to produce composite coatings based on nanosized bioactive glass and PCL, which are of interest as soft (deformable) bioactive coating in orthopedic applications.
Introduction
There are increasing research efforts to develop improved bioactive coatings with antibacterial function for orthopedic implants [1, 2] . It is well known that the quality of the interface between the implant and bone is critical for the success of the implant [3] . Bioactive coatings should avoid infections and support the attachment of bone on the implant surface. Combinations of biodegradable polymers and bioactive inorganic inclusions are being studied to develop a new class of "soft" or deformable coatings, e. g. containing a polymer component, as opposed to rigid and hard ceramic-only coatings, these developments include the use of stable polymers, e. g. PEEK [4, 5] as well as natural and synthetic biodegradable polymers [2, [6] [7] [8] [9] .
Polycaprolactone (PCL) is a biodegradable and biocompatible polyester which can remain in the human body up to several years after implantation [10] . PCL is semicrystalline, the degree of crystallinity can reach up to 69%, depending on the molecular weight of the polymer [10] . PCL is being investigated for numerous applications in the biomedical field, including drug delivery, scaffolds for tissue engineering, wound dressings and contraceptives [10] [11] [12] . Moreover electrophoretically deposited composites combining PCL and hydroxyapatite (HA) particles have been also developed [9] . Bioactive silicate glasses are being highly considered for developing coatings for orthopedic applications [13] [14] [15] [16] . The original bioactive glass composition, 45S5 Bioglass® (chemical composition in wt.%: SiO2 45, CaO 24.5, Na2O 24.5, P2O5 6.0), has a very high surface reactivity in aqueous environment which leads to the well-known bioactivity of this material, e.g. characterized by the formation of a hydroxyapatite layer on the material when it is immersed in relevant biological fluids, e.g. simulated body fluid (SBF) [13, 17] . In addition, the dissolution products of Bioglass® are able to upregulate several genes like the insulin-like growth factor II (IGF-II) in osteoblasts to promote bone formation [18, 19] and they can induce an angiogenic effect in vitro and in vivo [20] . Bioactive glasses (and glass-ceramics) of different silicate compositions are being increasingly investigated for developing orthopedic coatings, however specific silicate compositions are required to match the thermal expansion coefficient of the glass to that of the metallic substrate, e.g. Ti or Ti alloys [21] . The problem of thermal expansion mismatch and other issues related to the use of high temperatures for densification of bioactive glass and glass-ceramic coatings can be avoided if polymer-bioactive glass composite coatings are produced. For example, micron-size Bioglass® particles have been used in combination with PEEK for the electrophoretic fabrication of coatings on stainless steel and NiTi alloys [4] . Micrometric Bioglass® particles have been also used in combination with chitosan to produce coatings by electrophoretic deposition (EPD) [22] . The use of bioactive glass nanoparticles is of great interest as these nanoparticles (Bioglass® composition) have shown higher bioactivity and higher ability to adsorb proteins on their surface than conventional (micron-sized) bioactive glasses [23, 24] . Furthermore nanosized bioactive glass exhibits a significant antibacterial effect because of the high surface reactivity and increased release of silica ions [23] . In this work the development of PCL-nanosized bioactive glass coatings was investigated for the first time. Electrophoretic deposition was the technique chosen for fabrication of composite coatings on stainless steel substrates. Despite the numerous reported applications of EPD in the biomedical field [25] , which have taken advantage of the simplicity and versatility of the technique to assemble fine particles into dense deposits and films, the use of EPD to develop coatings based on bioactive glass (Bioglass®-type) nanoparticles has not been reported extensively to the authors knowledge. Thus the objective of this study was to explore the suitability of EPD to produce novel bioactive coatings based on an attractive combination of nanosized bioactive glass and PCL.
Materials and Methods
PCL (Aldrich, 6 -Caprolactone polymers) and nanosized bioactive glass particles of size in the range 20-80 nm were used. The nanosized BG particles were produced at ETH Zurich by the flame-spraying process, which leads, in comparison to other processing routes, to superior control of the particle size, homogeneity and composition [26] . These nanoparticles had a composition (in wt%): 47.8 % SiO 2 , 25.1 % CaO, 22.6 % Na 2 O and 4.6 % P 2 O 5 , i. e. very close to 45S5 Bioglass®. Studies in SBF have revealed a higher HA forming ability on nanosized BG than on the standard micrometric bioactive glass [24] . DMC was purchased from Sigma Aldrich. Stainless steel sheets (area: 3 x 1.5 cm2, thickness: 0.2 mm) were used as substrates. These were cleaned in ethanol (Emsure, 99%) before their use in the EPD cell. For preparation of polymer solutions, 0.5 g, 0.36 g or 0.7 g of PCL were dissolved in 15 ml of DMC at a temperature of 50°C on a magnetic stirrer. The bioactive glass suspensions were made by dispersing 0.15 g, 0.2 g or 0.25 g bioactive glass nanoparticles in 15 ml ethanol in an ultrasonic bath for 15 min. Both suspensions were mixed. To adjust the pH, 1 ml of 1 molar NaOH or 1 ml of 1 molar HCL was added. The mixtures were then stirred for two minutes at room temperature. Nanosized bioactive glass particles develop a positive surface charge in ethanol, which leads to cathodic deposition. The electrode distance was constant at 1 cm. A trial-and-error approach was used to determine the suitable EPD process parameters. The applied voltage was varied in the range of 20 V to 40 V and the deposition time was controlled between 90 and 600 s. Deposition rates at different times and voltages were analyzed. For the calculation of the deposition rates, the metal substrate was weighted before and after the deposition and the increase in weight per cross sectional area was determined. The coatings were characterized by Raman spectroscopy (Jobin Yvon Horiba HR800), bioactivity tests in SBF (according to the method introduced by Kokubo [27] ), scanning electron microscopy (SEM) (Fei, Quanta 200) and tape adhesion testing. SBF immersion tests were carried out at 37°C in an orbital shaker (IKA, KS 4000 control) for periods of 1, 5, 10 and 15 days. Samples of dimensions of 2 x 1.5 cm2 were introduced in 50ml SBF, which was not changed during the experimental time. The possible hydroxyapatite formation on coating surfaces after 1, 5, 10 and 15 days of immersion in SBF was checked by Raman spectroscopy and SEM. For qualitative assessment of the coating adhesion to the substrates, the tape test (DIN EN ISO 2409) was used. The hydropilicity of the coating was investigated by contact angle measurements using deionized water as test liquid.
Results and discussion
Preliminary EPD experiments were carried out in alkaline and acidic conditions. Electrophoretic deposition under alkali conditions caused high inhomogeneity of the coating (deposited on the cathode); while coatings produced under acidic conditions were much more homogeneous, as assessed by visual inspection. This effect can be explained considering the suspension viscosity. Adding NaOH was seen to cause a significant increase in viscosity leading to decreased homogeneity of the deposits. Adding HCl did not cause an hydrolysis effect, the viscosity did not increase and the coatings obtained by EPD were much more homogeneous. The mass of the deposits at a constant PCL concentration (6.45 g/l) and at different concentrations of bioactive glass nanoparticles was determined. Voltage, deposition time and electrode distance were kept constant for this part of the study. At these conditions (30V, 2 min, 1cm electrode distance), it was observed that the mass of the deposit was very low and only bioactive nanosized glass particles were deposited. PCL molecules were not deposited by EPD, which suggests that PCL was not charged in the solvent used. This result is in agreement with the results of Xiao et al. [9] , who worked on PCL/HA coatings by EPD. The result was confirmed by carrying out EPD of pure PCL suspension and dip coating samples in pure PCL solution. EPD of pure PCL created no coating while dipcoated samples in PCL/bioactive glass suspensions contained no bioactive glass. In the present experiment also an effect of bioactive glass concentration on the deposited mass was observed, as seen in Figure 1 , where the PCL concentration was kept constant at 16.13 g/l.
The maximum yield was obtained at a bioactive glass concentration of 6.45 g/l applying a voltage of 30V and a deposition time of 2min. The influence of the electric field on EPD yield was quite large if the electric field was increased from 20 V/cm to 30 V/cm but the increase from 30 V/cm to 40 V/cm did not affect significantly the deposition yield. For the deposition time there was a linear dependence between the deposited mass and time for deposition periods of up to 180 seconds. For a deposition time of 600s, the coatings were seen to be highly inhomogeneous. The characterization of coatings was carried out on those coatings which were qualitatively more homogeneous, e. g. coatings produced at 30 V/cm for 2 minutes. Raman spectroscopy spectra (Fig. 3) confirmed the coexistence of both materials in the composite coatings (dip-coated PCL and electrophoretically deposited nano-BG). Characteristic peaks for PCL are at wavenumbers of 913, 958, 1032, 1064 and 1100 cm-1 [28] . SEM pictures showed the infiltration of the nanosized bioactive glass particles by PCL (Fig. 4) . PCL fibrils are seen to be situated inbetween bioactive glass nanoparticles (Fig. 4a) and they should thus improve the mechanical properties of the coating. The cross section of the coating (Fig. 4b) shows a fairly homogeneous packing of bioactive glass particles leading to a coating thickness in the range of 5μm. The coating was detached from the substrate by the preparation of the sample for SEM, which confirms a mechanically stable coating, with good adhesion between the PCL and the BG particles.
To test the bioactivity of the coating, immersion tests in SBF following Kokubo's protocol [27] were carried out. After 1 day in SBF the beginning of formation of hydroxyapatite was detected. Figure 5 shows Raman spectroscopy results on selected samples. The characteristic peak for hydroxyapatite occurs at a wavenumber of 959.50 cm-1, this is the peak due to the symmetric stretching of the phosphate bond [29] . It was shown that already after 1 day of immersion, a change in the surface chemistry occurred. The amount of formed hydroxyapatite increases as expected with increasing immersion time in SBF. HA formation on the coating immersed in SBF was confirmed by SEM observations, as shown in Fig. 6 , which is a SEM micrograph of a composite sample after 10 days in SBF. The formation of hydroxyapatite is characterized by a cauliflower-like microstructure [30] , which can be seen in the upper part of the SEM image. The adhesion of the coating to the substrate was analyzed by the tape test (DIN EN ISO 2409). The tape test is a qualitative method which was used here to compare the relative adhesion of coatings with different concentrations of BG. The coatings are scratched in squares and a special tape is fixed on the surface. The tape is then slowly removed from the coating and the coatings are investigated by light microscopy. Fig. 7 shows the different coatings. The white parts in the pictures show the stainless steel substrate and the scratches that were made on the coatings, whereas the dark grey parts are the regions where the coating was removed. Before applying the tape, the squares are completely filled with the coating material, which is then removed by the tape depending on the adhesion of the coating to the substrate material. It could be seen that parts of the coatings were removed by the tape. Concerning the behavior of different nanosized bioactive glass particle concentrations (Fig. 7a-c) , it was seen that the higher the nanoparticle concentration the more coating remained adhered to the substrate after the tape test, which shows on the one hand a higher deposition, but on the other hand also a better adhesion to the substrate material, which is probably due to the fact that the BG particles are surrounded by PCL after the deposition.. The increase in PCL concentration showed a better fixation of the nanosized particles ( Fig. 7d-f) . At higher PCL concentration a larger amount of polymer phase is available in the coatings to fix the nanoparticles, which are more difficult to be removed by the tape. The coating's extent of hydrophilicity was tested by contact angle measurements using deionised water. Pure PCL pellets and composite coatings were investigated and results are shown in table 1. Addition of bioactive glass led to more hydrophilic coatings, as expected. In fact the addition of Bioglass® particles to polymers is an effective method to control hydrophility, for example in PLLA membranes [31] . The hydrophilicity of the surface is important as it will affect the interaction with proteins and cells. If the surface is too hydrophobic, cells will usually not adhere on the surface [32] . Therefore it is important to create a hydrophilic surface, and the extent of hydrophilicity can
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be tuned in these coatings by the bioactive glass concentration. As can be seen by the above results, the hydrophilicity of the PCL/BG composite can be adjusted by the BG content in the composite coating.
Conclusion
This work has shown that metal substrates can be coated with PCL and nanosized bioactive glass particles by a single EPD process. The glass particles are deposited electrophoretically, while PCL is deposited by physical deposition. The tape test showed an improvement in the adhesion of the coatings to the substrate material with increasing PCL content. SEM pictures showed that PCL fibrils have infiltrated the nanostructured glass coating and they could bridge the particles, which can lead to improved adhesion of the coating to the substrate and can enhance the flexibility of the coatings. Measurement of zeta potential to characterize the stability of the starting suspensions will be carried out in the future optimization of this EPD process. The coatings are bioactive; the formation of hydroxyapatite was confirmed after 5 days in SBF. These coatings belong to an increasing family of soft (as opposed to rigid, ceramic-only coatings) and bioactive electrophoretic coatings being developed for orthopedic and dental applications. Further characterization studies of the produced coatings, especially regarding cell culture tests in vitro are planned to get a better understanding of the relevance of these novel coatings for biomedical applications in orthopedics.
